Interstitial lung disease is a blanket term for a big group of disorders categorized by progressive scarring of both the lung tissue supporting and between the air sacs. This tissue is called the interstitium. The interstitium consists of the region between the alveolar space and the capillaries. The scarring causes inflammation and damage in the lung tissue followed by lung stiffness, meaning the air sacs cannot expand as much as before. Lung stiffness makes it harder to breathe. People affected by the condition are not able to get enough oxygen from the lungs into their bloodstream.
Although some potential causes have been researched, there may be no underlying cause for development of interstitial lung disease. If there is no known cause, it is called idiopathic interstitial lung disease. IPF or idiopathic pulmonary fibrosis remains the most common type of this illness. Of the causes most widely recognized, cigarette smoking is said to potentially make the disease more severe and the progression and onset more rapid. Although there are treatments, once lung scarring begins there is no means of reversing the damage.
Symptoms vary, but generally include a dry cough as well as shortness of breath either from after exertion or at rest. Other symptoms are often restricted to the respiratory tract. The condition is long-term lasting years or for some, can be lifelong. People most affected by the disorder is anyone over the age of 19 with many experiencing it after the age of 60. While it is a rare disorder, there are 200,000 cases reported annually in the United States. When people with a disease that falls within this category undergo physical examination, they will typically have bilateral inspiratory fine crackles. These are seen clearly seen at the lung bases. What should not be expected when examining is expiratory wheezing as it is relatively uncommon. If any skin rashes or joint deformities are present, this may signal underlying connective tissue...
Chronic Obstructive Pulmonary Disease (COPD) COPD constitutes a major source of mortality and morbidity across the globe, with a considerable economic effect. New GOLD (Global initiative for chronic Obstructive Lung Disease) guidance modifications refined patient classification for therapy by employing spirometry, exacerbation rate and symptom evaluation combined. Therapy attempts at decreasing both extant disease symptoms and vulnerability to adverse health conditions in the future. On account of their established effectiveness, the
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now